TOPICS

Tag: minocycline

Minocycline Extended-Release Comparison with Doxycycline for the Treatment of Rosacea: A Randomized, Head-to-Head, Clinical Trial

J Clin Aesthet Dermatol. 2021;14(12):16–23. by Anthanasios Tsianakas, MD; Thomas Pieber, MD; Hilary Baldwin, MD; Franz Feichtner, PhD; Shanavas Alikunju, PhD; Anirudh Gautam, MPharm; Srinivas Shenoy, MD; Preeti Singh, MD; and Srinivas Sidgiddi, MD Dr. Tsianakas is with the Department of Dermatology at Fachklinik Bad Bentheim in Bad Bentheim, Germany. Dr. Pieber is with the

CONTINUE READING »

Safety and Pharmacokinetics of FMX103 (1.5% Minocycline Topical Foam) in Subjects with Moderate-to-Severe Papulopustular Rosacea under Maximum-use Treatment Conditions

J Clin Aesthet Dermatol. 2021;14(3):E53–E57.  by Terry M. Jones, MD, and Iain Stuart, PhD Dr. Jones is with J&S Studies Inc., in College Station, Texas. Dr. Stuart is with VYNE Therapeutics Inc., in Bridgewater, New Jersey.  FUNDING: This study was sponsored by Foamix Pharmaceuticals Ltd., a wholly owned subsidiary of VYNE Therapeutics Inc. DISCLOSURES: Dr.

CONTINUE READING »

A Case of Minocycline-induced Linear Morphea Reactivation

J Clin Aesthet Dermatol. 2021;14(2):44–45. by Cory Pettit, MD, and Joy Mosser-Goldfarb, MD Drs. Pettit and Mosser-Goldfarb are with the Division of Dermatology, Department of Internal Medicine, The Ohio State University Wexner Medical Center in Columbus, Ohio. FUNDING: No funding was provided for this article. DISCLOSURES: The authors report no conflicts of interest relevant to

CONTINUE READING »

Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea

J Clin Aesthet Dermatol. 2020;13(11):44–49 by Linda Stein Gold, MD; James Q. Del Rosso, DO; Leon Kircik, MD; Neal D. Bhatia, MD; Deirdre Hooper, MD; Walter Nahm, MD, PhD; and Iain Stuart, PhD Dr. Stein Gold is with the Henry Ford Health System in Detroit, Michigan. Dr. Del Rosso is the Research Director at JDR

CONTINUE READING »